{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:46:05Z","timestamp":1793670365270,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95336","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:24:38Z","timestamp":1761323078000},"source":"Crossref","is-referenced-by-count":7,"title":["Seasonal Influenza: A Narrative Review of Epidemiology, Clinical Features, and Preventive Strategies"],"prefix":"10.7759","author":[{"given":"Yousif","family":"Kyokha Ameen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Influenza (seasonal). (2025). Accessed. 08\/10\/2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref2","unstructured":"How flu spreads\r\n. (2023). Accessed. 08\/10\/2025: https:\/\/www.cdc.gov\/flu\/spread\/index.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad577","article-title":"Evolution of influenza A(H3N2) viruses in 2 consecutive seasons of genomic surveillance, 2021-2023","volume":"10","author":"Fall A","year":"2023","unstructured":"Fall A, Han L, Yunker M, et al.. Evolution of influenza A(H3N2) viruses in 2 consecutive seasons of genomic surveillance, 2021-2023. Open Forum Infect Dis. 2023, 10:577. 10.1093\/ofid\/ofad577","journal-title":"Open Forum Infect Dis"},{"key":"ref4","article-title":"Handbook of Geographical and Historical Pathology","author":"Hirsch A","year":"1883","unstructured":"Hirsch A. Handbook of Geographical and Historical Pathology. Creighton C (ed): New Sydenham Society, London, UK; 1883."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1098\/rstl.1694.0022","article-title":"IV. Dr. Molineux\u2019s historical account of the late general coughs and colds; with some observations on other epidemick distempers","volume":"18","author":"Molyneux T","year":"1694","unstructured":"Molyneux T. IV. Dr. Molineux\u2019s historical account of the late general coughs and colds; with some observations on other epidemick distempers\r\n. Philos Trans R Soc Lond. 1694, 18:105-11. 10.1098\/rstl.1694.0022","journal-title":"Philos Trans R Soc Lond"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic","volume":"76","author":"Johnson NP","year":"2002","unstructured":"Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic. Bull Hist Med. 2002, 76:105-15. 10.1353\/bhm.2002.0022","journal-title":"Bull Hist Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens5040066","article-title":"Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission","volume":"5","author":"Saunders-Hastings PR","year":"2016","unstructured":"Saunders-Hastings PR, Krewski D. Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission. Pathogens. 2016, 5:66. 10.3390\/pathogens5040066","journal-title":"Pathogens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v14.i3.109161","article-title":"Recent advances in avian influenza virus: molecular pathogenesis, emerging strains, and next-generation therapeutics","volume":"14","author":"Nagoba BS","year":"2025","unstructured":"Nagoba BS, Dhotre SV, Sonar MN, Gavkare AM, Mumbre SS, Dhotre PS. Recent advances in avian influenza virus: molecular pathogenesis, emerging strains, and next-generation therapeutics. World J Virol. 2025, 14:109161. 10.5501\/wjv.v14.i3.109161","journal-title":"World J Virol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington WN","year":"2021","unstructured":"Harrington WN, Kackos CM, Webby RJ. The evolution and future of influenza pandemic preparedness. Exp Mol Med. 2021, 53:737-49. 10.1038\/s12276-021-00603-0","journal-title":"Exp Mol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer F","year":"2018","unstructured":"Krammer F, Smith GJ, Fouchier RA, et al.. Influenza. Nat Rev Dis Primers. 2018, 4:3. 10.1038\/s41572-018-0002-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4794910","article-title":"Different subtypes of influenza viruses target different human proteins and pathways leading to different pathogenic phenotypes","volume":"2019","author":"Wang Y","year":"2019","unstructured":"Wang Y, Song T, Li K, Jin Y, Yue J, Ren H, Liang L. Different subtypes of influenza viruses target different human proteins and pathways leading to different pathogenic phenotypes. Biomed Res Int. 2019, 2019:4794910. 10.1155\/2019\/4794910","journal-title":"Biomed Res Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1613869","article-title":"Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines","volume":"13","author":"Possas C","year":"2025","unstructured":"Possas C, Marques ET, Oliveira A, et al.. Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines. Front Public Health. 2025, 13:1613869. 10.3389\/fpubh.2025.1613869","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1467029","article-title":"A comprehensive review of influenza B virus, its biological and clinical aspects","volume":"15","author":"Ashraf MA","year":"2024","unstructured":"Ashraf MA, Raza MA, Amjad MN, et al.. A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol. 2024, 15:1467029. 10.3389\/fmicb.2024.1467029","journal-title":"Front Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf185","article-title":"Vaccine effectiveness against influenza A(H1N1), A(H3N2), and B-associated hospitalizations, United States, 1 September 2023 to 31 May 2024","volume":"232","author":"Lewis NM","year":"2025","unstructured":"Lewis NM, Harker EJ, Cleary S, et al.. Vaccine effectiveness against influenza A(H1N1), A(H3N2), and B-associated hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025, 232:626-36. 10.1093\/infdis\/jiaf185","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.02.002","article-title":"The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021","volume":"129","author":"Chen C","year":"2023","unstructured":"Chen C, Jiang D, Yan D, et al.. The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021. Int J Infect Dis. 2023, 129:118-24. 10.1016\/j.ijid.2023.02.002","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(79)90189-2","article-title":"Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations","volume":"96","author":"Webster RG","year":"1979","unstructured":"Webster RG, Kendal AP, Gerhard W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology. 1979, 96:258-264. 10.1016\/0042-6822(79)90189-2","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.05.009","article-title":"Influenza virus evolution, host adaptation, and pandemic formation","volume":"7","author":"Taubenberger JK","year":"2010","unstructured":"Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe. 2010, 7:440-51. 10.1016\/j.chom.2010.05.009","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040645","article-title":"Efforts to improve the seasonal influenza vaccine","volume":"8","author":"Cianci R","year":"2020","unstructured":"Cianci R, Newton EE, Pagliari D. Efforts to improve the seasonal influenza vaccine. Vaccines (Basel). 2020, 8:645. 10.3390\/vaccines8040645","journal-title":"Vaccines (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2024.0893","article-title":"Preventing influenza virus infection and severe influenza among pregnant people and infants","volume":"33","author":"Olson SM","year":"2024","unstructured":"Olson SM, Dawood FS, Grohskopf LA, Ellington S. Preventing influenza virus infection and severe influenza among pregnant people and infants. J Womens Health (Larchmt). 2024, 33:1591-8. 10.1089\/jwh.2024.0893","journal-title":"J Womens Health (Larchmt)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126839","article-title":"Global production capacity of seasonal and pandemic influenza vaccines in 2023","volume":"51","author":"Taaffe J","year":"2025","unstructured":"Taaffe J, Goldin S, Lambach P, Sparrow E. Global production capacity of seasonal and pandemic influenza vaccines in 2023. Vaccine. 2025, 51:126839. 10.1016\/j.vaccine.2025.126839","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3707-y","article-title":"Recognition of aerosol transmission of infectious agents: a commentary","volume":"19","author":"Tellier R","year":"2019","unstructured":"Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019, 19:101. 10.1186\/s12879-019-3707-y","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00409-24","article-title":"Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria","volume":"98","author":"David SC","year":"2024","unstructured":"David SC, Schaub A, Terrettaz C, et al.. Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria. J Virol. 2024, 98:0040924. 10.1128\/jvi.00409-24","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvae150","article-title":"Virus evolution in prolonged infections of immunocompromised individuals","volume":"71","author":"Raglow Z","year":"2025","unstructured":"Raglow Z, Lauring AS. Virus evolution in prolonged infections of immunocompromised individuals. Clin Chem. 2025, 71:109-18. 10.1093\/clinchem\/hvae150","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133698","article-title":"Pulmonary function and clinical manifestations of patients infected with mild influenza A virus subtype H1N1: a one-year follow-up","volume":"10","author":"Liu W","year":"2015","unstructured":"Liu W, Peng L, Liu H, Hua S. Pulmonary function and clinical manifestations of patients infected with mild influenza A virus subtype H1N1: a one-year follow-up. PLoS One. 2015, 10:0133698. 10.1371\/journal.pone.0133698","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00982-5","article-title":"Influenza","volume":"400","author":"Uyeki TM","year":"2022","unstructured":"Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet. 2022, 400:693-706. 10.1016\/S0140-6736(22)00982-5","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.21037\/tp-20-196","article-title":"Clinical features and outcomes of influenza by virus type\/subtype\/lineage in pediatric patients","volume":"10","author":"Han SB","year":"2021","unstructured":"Han SB, Rhim JW, Kang JH, Lee KY. Clinical features and outcomes of influenza by virus type\/subtype\/lineage in pediatric patients. Transl Pediatr. 2021, 10:54-63. 10.21037\/tp-20-196","journal-title":"Transl Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.02.014","article-title":"Comparison of chest-CT findings of influenza virus-associated pneumonia in immunocompetent vs. immunocompromised patients","volume":"84","author":"Kloth C","year":"2015","unstructured":"Kloth C, Forler S, Gatidis S, et al.. Comparison of chest-CT findings of influenza virus-associated pneumonia in immunocompetent vs. immunocompromised patients. Eur J Radiol. 2015, 84:1177-83. 10.1016\/j.ejrad.2015.02.014","journal-title":"Eur J Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093175","article-title":"Role of respiratory viruses in severe acute respiratory failure","volume":"14","author":"Mokrani D","year":"2025","unstructured":"Mokrani D, Timsit JF. Role of respiratory viruses in severe acute respiratory failure. J Clin Med. 2025, 14:3175. 10.3390\/jcm14093175","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-023-01234-y","article-title":"Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study","volume":"12","author":"Yi G","year":"2023","unstructured":"Yi G, de Kraker ME, Buetti N, et al.. Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study. Antimicrob Resist Infect Control. 2023, 12:25. 10.1186\/s13756-023-01234-y","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12089","article-title":"Bacterial and viral infections associated with influenza","volume":"7 Suppl 2","author":"Joseph C","year":"2013","unstructured":"Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses. 2013, 7 Suppl 2:105-13. 10.1111\/irv.12089","journal-title":"Influenza Other Respir Viruses"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris DE","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017, 8:1041. 10.3389\/fmicb.2017.01041","journal-title":"Front Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12007","article-title":"Influenza myocarditis: a literature review","volume":"12","author":"Baral N","year":"2020","unstructured":"Baral N, Adhikari P, Adhikari G, Karki S. Influenza myocarditis: a literature review. Cureus. 2020, 12:12007. 10.7759\/cureus.12007","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144123","article-title":"Influenza myopericarditis and pericarditis: a literature review","volume":"11","author":"Radovanovic M","year":"2022","unstructured":"Radovanovic M, Petrovic M, Barsoum MK, et al.. Influenza myopericarditis and pericarditis: a literature review. J Clin Med. 2022, 11:4123. 10.3390\/jcm11144123","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14030237","article-title":"Acute influenza virus-associated encephalitis and other neurological complications in severe hospitalized laboratory-confirmed influenza cases-Catalonia 2010-2020","volume":"14","author":"Ciruela P","year":"2025","unstructured":"Ciruela P, Soldevila N, Torner N, et al.. Acute influenza virus-associated encephalitis and other neurological complications in severe hospitalized laboratory-confirmed influenza cases-Catalonia 2010-2020. Pathogens. 2025, 14:237. 10.3390\/pathogens14030237","journal-title":"Pathogens"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038430","article-title":"Influenza in children","volume":"11","author":"Nayak J","year":"2021","unstructured":"Nayak J, Hoy G, Gordon A. Influenza in children. Cold Spring Harb Perspect Med. 2021, 11:038430. 10.1101\/cshperspect.a038430","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix461","article-title":"Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis","volume":"65","author":"Bruning AH","year":"2017","unstructured":"Bruning AH, Leeflang MM, Vos JM, Spijker R, de Jong MD, Wolthers KC, Pajkrt D. Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clin Infect Dis. 2017, 65:1026-32. 10.1093\/cid\/cix461","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00284.x","article-title":"Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis","volume":"6","author":"Chu H","year":"2012","unstructured":"Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR. Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza Other Respir Viruses. 2012, 6:80-6. 10.1111\/j.1750-2659.2011.00284.x","journal-title":"Influenza Other Respir Viruses"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-7-201204030-00403","article-title":"Accuracy of rapid influenza diagnostic tests: a meta-analysis","volume":"156","author":"Chartrand C","year":"2012","unstructured":"Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012, 156:500-11. 10.7326\/0003-4819-156-7-201204030-00403","journal-title":"Ann Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-011-0999-7","article-title":"VereFlu\u2122: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology","volume":"156","author":"Teo J","year":"2011","unstructured":"Teo J, Di Pietro P, San Biagio F, et al.. VereFlu\u2122: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology. Arch Virol. 2011, 156:1371-8. 10.1007\/s00705-011-0999-7","journal-title":"Arch Virol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05010-11","article-title":"Comparison of the FilmArray respiratory panel and Prodesse real-time PCR assays for detection of respiratory pathogens","volume":"49","author":"Loeffelholz MJ","year":"2011","unstructured":"Loeffelholz MJ, Pong DL, Pyles RB, Xiong Y, Miller AL, Bufton KK, Chonmaitree T. Comparison of the FilmArray respiratory panel and Prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol. 2011, 49:4083-8. 10.1128\/JCM.05010-11","journal-title":"J Clin Microbiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies","volume":"156","author":"Hsu J","year":"2012","unstructured":"Hsu J, Santesso N, Mustafa R, et al.. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012, 156:512-24. 10.7326\/0003-4819-156-7-201204030-00411","journal-title":"Ann Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri SG","year":"2014","unstructured":"Muthuri SG, Venkatesan S, Myles PR, et al.. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014, 2:395-404. 10.1016\/S2213-2600(14)70041-4","journal-title":"Lancet Respir Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170920165926","article-title":"Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance","volume":"25","author":"Han J","year":"2018","unstructured":"Han J, Perez J, Schafer A, Cheng H, Peet N, Rong L, Manicassamy B. Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance. Curr Med Chem. 2018, 25:5115-27. 10.2174\/0929867324666170920165926","journal-title":"Curr Med Chem"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt AC","year":"2014","unstructured":"Hurt AC. The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol. 2014, 8:22-9. 10.1016\/j.coviro.2014.04.009","journal-title":"Curr Opin Virol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden FG","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, et al.. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018, 379:913-23. 10.1056\/NEJMoa1716197","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02996-2","article-title":"Correction to: the effect of corticosteroids on the mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"24","author":"Ni YN","year":"2020","unstructured":"Ni YN, Chen G, Sun J, Liang BM, Liang ZA. Correction to: the effect of corticosteroids on the mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care. 2020, 24:376. 10.1186\/s13054-020-02996-2","journal-title":"Crit Care"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis","volume":"48","author":"Lansbury LE","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med. 2020, 48:98-106. 10.1097\/CCM.0000000000004093","journal-title":"Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos EL","year":"2015","unstructured":"Ramos EL, Mitcham JL, Koller TD, et al.. Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza. J Infect Dis. 2015, 211:1038-44. 10.1093\/infdis\/jiu539","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01027-20","article-title":"Matrix protein 2 extracellular domain-specific monoclonal antibodies are an effective and potentially universal treatment for influenza A","volume":"95","author":"Bimler L","year":"2021","unstructured":"Bimler L, Ronzulli SL, Song AY, et al.. Matrix protein 2 extracellular domain-specific monoclonal antibodies are an effective and potentially universal treatment for influenza A. J Virol. 2021, 95:01027-20. 10.1128\/JVI.01027-20","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner A","year":"2004","unstructured":"Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol. 2004, 172:5598-605. 10.4049\/jimmunol.172.9.5598","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx3505","article-title":"Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations","volume":"11","author":"Kim T","year":"2025","unstructured":"Kim T, Bimler L, Ronzulli SL, et al.. Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. Sci Adv. 2025, 11:3505. 10.1126\/sciadv.adx3505","journal-title":"Sci Adv"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1086\/498984","article-title":"Influenza immunity: new insights from old studies","volume":"193","author":"Kilbourne ED","year":"2006","unstructured":"Kilbourne ED. Influenza immunity: new insights from old studies. J Infect Dis. 2006, 193:7-8. 10.1086\/498984","journal-title":"J Infect Dis"},{"key":"ref53","unstructured":"Global influenza programme. (2024). Accessed. 08\/10\/2025: https:\/\/www.who.int\/teams\/global-influenza-programme\/vaccines."},{"key":"ref54","unstructured":"Recommended composition of influenza virus vaccines for use in the 2024-2025 northern hemisphere influenza season. (2024). Accessed. 08\/10\/2025: https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-...."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20220518-01090","article-title":"Introduction and implications of WHO position paper: vaccines against influenza, May 2022 (Article in Chinese)","volume":"102","author":"Feng LZ","year":"2022","unstructured":"Feng LZ, Jiang HY, Yi J, et al.. Introduction and implications of WHO position paper: vaccines against influenza, May 2022 (Article in Chinese). Zhonghua Yi Xue Za Zhi. 2022, 102:2315-8. 10.3760\/cma.j.cn112137-20220518-01090","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063773","article-title":"Recommendations for prevention and control of influenza in children, 2023-2024","volume":"152","year":"2023","unstructured":"Recommendations for prevention and control of influenza in children, 2023-2024. Pediatrics. 2023, 152.2023063773. 10.1542\/peds.2023-063773","journal-title":"Pediatrics"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxz008","article-title":"Global geographical and temporal patterns of seasonal influenza and associated climatic factors","volume":"41","author":"Dave K","year":"2019","unstructured":"Dave K, Lee PC. Global geographical and temporal patterns of seasonal influenza and associated climatic factors. Epidemiol Rev. 2019, 41:51-68. 10.1093\/epirev\/mxz008","journal-title":"Epidemiol Rev"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050714","article-title":"Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines","volume":"10","author":"Trombetta CM","year":"2022","unstructured":"Trombetta CM, Kistner O, Montomoli E, Viviani S, Marchi S. Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines (Basel). 2022, 10:9143275. 10.3390\/vaccines10050714","journal-title":"Vaccines (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae658","article-title":"Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season","author":"Chung JR","year":"2025","unstructured":"Chung JR, Price AM, Zimmerman RK, et al.. Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season. Clin Infect Dis. 2025, 658. 10.1093\/cid\/ciae658","journal-title":"Clin Infect Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000593","article-title":"Pregnancy and severe influenza infection in the 2013-2014 influenza season","volume":"125","author":"Louie JK","year":"2015","unstructured":"Louie JK, Salibay CJ, Kang M, Glenn-Finer RE, Murray EL, Jamieson DJ. Pregnancy and severe influenza infection in the 2013-2014 influenza season. Obstet Gynecol. 2015, 125:184-92. 10.1097\/AOG.0000000000000593","journal-title":"Obstet Gynecol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005479","article-title":"Influenza in pregnancy: prevention and treatment: ACOG committee statement No. 7","volume":"143","year":"2024","unstructured":"Influenza in pregnancy. prevention and treatment: ACOG committee statement No. 7. Obstet Gynecol. 2024, 143:24-30. 10.1097\/AOG.0000000000005479","journal-title":"Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422320-seasonal-influenza-a-narrative-review-of-epidemiology-clinical-features-and-preventive-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:24:40Z","timestamp":1761323080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422320-seasonal-influenza-a-narrative-review-of-epidemiology-clinical-features-and-preventive-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.95336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}